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The effects of in vivo administration of prostaglandin E1 (PGE1) on rat parotid 
gland acinar cells were studied and compared with glands removed from 
animals which had been either fasted or stimulated to discharge stored secretory 
granules by an injection of isoproterenol (IPR). Depletion of tissue amylase, 
increased plasma amylase, and alterations in secretory cell ultrastructure were 
used to assess the effects of PGE,. Initially following PGE1 administration, 
the secretory granules enlarged their matrices and lost electron opacity, and 
numerous fusions between secretory granules occurred. Concomitant with the 
above events, material having an appearance identical to that within the 
secretory granules was observed in the acinar lumina and the intercellular 
spaces. The PGEl-induced release of stored secretory materials from storage 
granules was transient. Five hours after the onset of hourly PGE~ injections, 
the biochemical and structural features of the gland were "normal." The effects 
of PGE~ on the rat parotid gland are discussed. A theory of PGE1 action based 
on the translocation of ionic calcium is proposed. 
Accumulating evidence indicates that prostaglandins may play an active role in 
the function of the gastrointestinal tract (12). Of the organs comprising this system, 
the effects of prostaglandins have been studied in the stomach, exocrine pancreas, 
and intestine. Prostaglandins are released from these organs after neural and 
hormonal stimulation, and they affect both vascular and visceral smooth muscle in 
addition to secretory processes. It is the effect of prostaglandins upon exocrine secre- 
tion that will be further explored in the present study. 
While there are differing opinions as to the site of action of prostaglandins in the 
stomach, there is general agreement that prostaglandin E 1 (PGE1), PGE2, and some 
of their analogs inhibit gastric acid secretion (11, 12, 14) and, according to some, 
enzyme release (23). Prostaglandins in the pancreas appear to have a dual effect 
on the final secretory product; they decrease fluid volume and electrolyte content and 
increase the secretion of enzymes (24). The mechanism of prostaglandin action has 
been related to an equally ubiquitously distributed enzyme, adenyl cyclase. Horton 
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(9) and earlier Ramwell  and Shaw (19) proposed that  prostaglandins were formed 
consequent  to neural or hormona l  stimulation of adenyl cyclase and that, in the intact 
cell, prostaglandins act as a negative feedback mechanism limiting the activity of 
adenyl cyclase. Intr iguing as this proposal  seems, it unfortunately lacks universal 
application. Butcher et al. (4) among  others have demonstrated that  PG ' s  stimulate 
c A M P  format ion  in many  rat tissues and organs. 
The parot id gland of the rat was chosen for  this study of prostaglandin effects on 
exocrine secretion for  the following reasons: (1) the gland is a totally serous salivary 
gland having sufficient size to provide adequate quantities of tissue for  biochemical 
analysis; (2) amylase, the major  secretory protein of the gland, is relatively stable 
and its activity is easily assayed; and (3) the release of stored amylase f rom the gland 
has been established to be dependent upon, among  other factors, the elevation of 
cyclic A M P  (1, 26). This last observation indicating that  though prostaglandins 
have not  been isolated f rom the gland, an enzyme system, adenyl cyclase, upon  which 
this substance has been proposed to act, is present and integral to the secretory 
process. 
MATERIALS AND METHODS 
Animals. Male Sprague-Dawley rats weighing 250 _+ 15 g were used. The animals were 
fed pelleted rat chow ad libitum and housed under controlled light conditions (6 a.m. to 
8 p.m.) for 4 days prior to beginning experiments in an attempt to standardize secretory 
cycles. After acclimatization food was withheld for 15 hours prior to beginning the experi- 
ment. Experiments were initiated between 8 and 9 : 0 0  a.m. (time 0), when animals were 
injected subcutaneously with a freshly prepared salt of PGE1 (supplied by the Upjohn 
Company, Kalamazoo) in a dose of 25 #g/100 g b.w. Crystalline PGEI (1 rag) was first 
dissolved in 95 % ethanol (0.2 ml). While stirring this solution, 1.8 mM sodium carbonate 
in water (1.8 ml) was then rapidly added to give a final solution with a pH in the range of 
6-7.5. To circumvent the rapid metabolic breakdown reported for PGE1, hourly injections 
were given. This dose and regimen were based on previous studies of gastric mueosa in 
which a similar injection regimen was shown to effectively block secretion (23). For the 
purpose of further comparison, the effect of the drug on secretion was contrasted not only 
to fasted controls, but also to isoproterenol (IPR)-treated animals. This drug, dissolved 
in saline, was administered intraperitoneally as a single injection of 0.8 rag/100 g b.w. at 
time 0 noted above. At the end of an experimental time period, animals were treated by one 
of two methods depending upon the nature of the particular experiment: (1) killed by a 
blow to the head prior to biochemical studies or (2) anesthetized with chloral hydrate (i.p. 
injection of 7 % chloral hydrate, 0.5 ml/100 g b.w.) in preparation for morphological observa- 
tions. 
Determination of amylase in the tissues and plasma. Tissue amylase was extracted by 
homogenization of the tissue in distilled water. After centrifugation, the supernatant was 
assayed for its amylase activity. Alpha amylase activity was determined by hydrolysis of 
Cibachrome Blue F3 GA-amylose substrate as described in a previous paper (13). Parallel 
aliquots were precipitated with 0.5 N PCA and the D N A  extracted from the precipitate 
52 LILLIE 




d l - -  
o m 60  
g~ ¢-., 
4 o  
13- 





.. . . . . . .  PGE 1 
- - - - - -  CONTROL 
1(AMYLASE UNITS) 
,ug DNA 
"°'°°%°° ° °, ,°. ,  ,°o°° • °°'° '°°'°" ° 
.°° .° 
. . . , , -_________m:=:~ ' - ' .  ~ . . . .  ~ .~  
I I I I I I I 
2 3 4 5 6 7 8 9 I0  
HOURS FOLLOWING INITIAL INJECTION 
FIG. 1. Restitution of parotid gland amylase following PGE1 and IPR-induced release is shown 
over the lO-hour period studied. 
by acid hydrolysis at 70°C. DNA content of the hydrolyzate was determined using the 
diphenylamine reaction (3) and comparing it to known concentrations of calf thymus DNA. 
Comparison between experimental (PGE1 treated), IPR stimulated, and control (fasted) 
animals were made 1, 5, and 10 hours after the initial (PGEI, IPR, or sham) injection and 
based on their DNA content in order to avoid errors caused by hydration in the use of wet 
tissue weight or by the choice of a total protein index in a secretory model in which 50 % 
of all the protein of the gland is exportable (25). 
Plasma amylase activity 1 hour after the initial injection was determined by the same 
assay procedure used for tissue amylase, but groups of animals were compared on the basis 
of microliters of heparinized plasma. Blood for these studies was removed from the left 
ventricle prior to perfusion of the animal for electron microscopic studies. 
Electron microscopy. For electron microscopy, anesthetized animals were perfused via 
left ventricular injection with prewarmed (37°C) 2 % paraformaldehyde and 2.5 % glutaral- 
dehyde in 0.1 M phosphate buffer pH 7.2. (10). Approximately 70 ml were perfused over a 
10-minute period. After removal and dicing the gland tissue, fixation in the perfusate 
was confined for 1 hour. The tissues were then rinsed in 0.1 M phosphate buffer containing 
4.5% sucrose prior to postfixation in 0.1 M phosphate buffered 1% osmium tetroxide. 
Following fixation, tissues were dehydrated through graded alcohols and propylene oxide, 
then embedded in Araldite:Epon (17). To assess the quality of fixation and the variation 
in morphology between individual lobules, sections 1/~m in thickness were stained with 1% 
toluidine blue (pH 9.3) and surveyed prior to thin sectioning. Thin sections were stained with 
uranyl acetate and lead citrate. Ultrastructural studies of the tissues were made at 1, 5, 
and 10 hours following the initial injection at time 0. 
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FIG. 2. Light micrographs of parotid glands demonstrating: (a) morphology of a fasted, control 
gland with normally appearing secretory granules in contrast to (b) a PGE1 treated gland where the 
secretory granules are much enlarged and more lightly stained, (a) × 650; (b) × 700. 
RESULTS 
Amylase levels of parotid gland and plasma 
Amylase levels in the gland following PGE1 and IPR treatment are compared to  
the fasted control in Fig. 1. Administration of PGE 1 led to an initial release of 28 % 
of the tissue amylase within 1 hour when compared with this enzyme's level in the 
fasted control gland (P-0 .01) .  Though administration of PGE1 was continued, the 
activity of amylase in the tissue returned to and slightly surpassed control levels 
(P=0.78)  5 hours after the first injection. In contrast to PGE~-treated animals, a 
single injection of IPR  resulted in the release of approximately 98 % of tissue amylase 
within 1 hour. Subsequently during the 9 hours following this discharge, IPR-treated 
glands resynthesized 38 % of the amylase found in fasted control glands. 
Plasma amylase 1 hour following either PGE~ or IPR  treatment was elevated above 
control levels. These elevations reflected rather closely the effectiveness of the two 
agents in releasing amylase from tissue stores. Plasma from PGE~-treated animals 
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averaged 1.26 times more activity than the control while their IPR counterparts 
had average plasma amylase activity values i.97 times the control value. 
Structural observations 
Structural changes in the parotid gland of the experimental animals were most 
marked 1 hour after the initial injection. The light micrographs of the fasted control 
(Fig. 2a) and PGE1 treated (Fig. 2b) glands demonstrated these initial changes in 
secretory granule structure and size. The granules were less dense and increased in 
size causing the acinar cells to appear enlarged and excessively filled with secretory 
granules. Ultrastructurally (Fig. 3), many of the enlarged granules were observed 
to have fused with adjacent granules. The electron opacity of stored secretory 
material was markedly reduced in PGE1 treated animals and was similar in appear- 
ance to the condensing vacuoles observed in fasted control glands. Flocculent 
material similar in appearance to the altered secretory granules could be found  not 
only within the acinar lumen and intercellular canaliculi, but also in the inter- 
cellular spaces separating the basal portions of the adjoining acinar cells. Material 
located in this later space was still contained within the acinar cell cluster by an 
intact basal lamina and was not found in the connective tissue stroma of the gland. 
Based on the structural changes observed above, the effect of PGE 1 during this 
period appeared to be limited to the secretory granules and apical and lateral plasma 
membranes. The morphology of cell organelles such as the nucleus, mitochondria, 
and rough endoplasmic reticulum appeared similar to those observed in control 
glands. The morphology of parotid glands removed from fasted, control, and IPR- 
treated animals using identical fixation techniques has been treated in detail else- 
where (13). Five and 10 hours after the onset of PGE1 injections most of the mem- 
brane changes that typified the earlier time period were reduced or absent (Fig. 4). 
Secretory granules while still less dense than control granules were considerably 
more dense than those described for the 1-hour time period. While adjoining surfaces 
of adjacent granules were flattened, there were fewer examples of granule fusion. 
There was also a consistent lack of flocculent material in any of the previously 
discussed extra- or intercellular spaces. 
In preliminary experiments samples of pancreas were also removed and processed 
F~G. 3. A parotid gland acinar cell 1 hour after PGE1 administration showing enlarged secretory 
granules (G). Breaks in the plasma membrane indicated by the arrows are probably artifacts and do 
not reflect the mode of release of secretory product into the intercellular space. Discharged secretory 
material is present in the acinar lumen (L), intercellular canaliculus (ic) and the intercellular space 
(is), although no secretory material appears to have crossed the basal lamina (bl) of the acinus, 
x 18 600. 
L,~!i,~,~!i ~ 
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for structural evaluation. No effects of PGE1 or IPR were observed in the exocrine 
cells with the dosages and regimen used in this study; therefore further observations 
were not made on the pancreas. 
DISCUSSION 
While the author recognizes that secretory granules of the parotid gland are 
notoriously difficult to preserve, the structural changes reported here are felt not to 
merely represent artifacts of fixation. During the time that secretory granules show 
maximum structural alteration and expelled secretory material can be shown within 
various extracellular and intercellular spaces, tissue amylase activity as studied in 
animals not processed for morphological study (which can be regarded as an in- 
dependent control) was significantly decreased while plasma amylase was elevated. 
Both structural and biochemical parameters simultaneously return to control values 
as the PGE1 injections continued. The elevation of plasma amylase during secretion 
which occurred in this study following PGE1 and IPR injections has not, to my 
knowledge, been previously reported in the literature; however, the phenomenon 
has been observed by Barka in his studies using IPR (2). Any explanation of how 
such an elevation of plasma amylase activity occurs is, at this point speculative, 
but reabsorption of the intact protein across the mucosa of the gastrointestinal tract 
can probably be ruled out on temporal grounds alone. Release of stored material 
into a nonluminal compartment with subsequent absorption into the capillaries of 
the gland would seem a most reasonable explanation at least in the case of PGE1 
treated animals. 
The most plausible explanation for the changes observed following PGE1 treatment 
can probably be related to the drug's translocation of the calcium ion. Prostaglandins 
by direct displacement of membrane-bound calcium have been found to affect 
major fluxes of Ca 2+ across both the plasma membrane (20) and the membranes of 
certain intracellular organelles (5, 28). While fluxes in Ca ~+ have also been reported 
to be integral in exocrine secretion following the activation of adenyl cyclase (6, 8, t6, 
28), the action of prostaglandins in inducing these ionic shifts has been reported 
to be independent of adenyl cyclase activity (5, 20, 28). Calcium has also been shown 
to be important not only in the maintenance of membrane structure (22), but also 
in the integrity of the secretory granule matrix (18). Pletcher et al. have shown 
Ca z+ and ATP in storage granules interact with secretory proteins to form "dynamic" 
complexes which osmotically stabilize the granule and allow concentration of 
secretory materials (18). While this later study was made in chromaffin granules of 
FIG. 4. A parotid gland acinar cell 5 hours after the onset of the PGE1 regimen. Secretory granule 
membranes are intact and the granule matrix demonstrates increased electron opacity. The acinar 
lumen (L) and intercellular space (is) do not contain secretory material. × 14 000. 
' ~ i ~ , ~ !  ~ • i i ~ ~ , , ~  • 'ii ~ • 
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the adrenal medulla, it has been found that secretory granules of the parotid gland 
contain large concentrations of Ca 2+ (27). 
With these facts and theories, the observed ultrastructural changes in the parotid 
following PGE~ treatment could be related to changes in levels or translocation of 
Ca 2+ displacement from a previously osmotically stable enzyme complex. 
The nature of the PGE1 effect cannot in any way be considered a "normal"  
secretory process (7, 15). In fact, the only similarity between the normal secretory 
process and the events that occur after PGE1 administration is the intracellular 
fusion of secretory granules. While fusion of the secretory granule membrane with 
the apical plasma membrane and the subsequent expulsion of the secretory product 
into the lumen ("normal release") has been observed after PGE 1 administration. 
I have not observed a similar process on the lateral aspects of the cell. Therefore, 
the mode of secretory product access to the intercellular space is not clear. To my 
knowledge, however, the presence of secretory material within the intercellular space 
has not been observed in glands stimulated to release their secretory product by either 
feeding (15) or IPR (13). It is therefore proposed that the action of PGE1 on the 
parotid gland is due to a direct effect on intracellular Ca 2+ rather than cyclase or 
cAMP which has been shown to participate in the normal parotid secretory event. 
The work was supported by National Institutes of Health Fellowship DE 43007 and Grant 
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